Built high-volume BMT programs across NCR; focuses on access, outcomes, and donor registry collaborations As Principal Director & Chief – Hematology, Hemato-Oncology & BMT at Fortis Memorial Research Institute (FMRI), Gurugram, they work within multidisciplinary tumor boards, integrate evidence ased protocols, and emphasize compassionate communication with patients and families.
Their practice balances complex inpatient care with day-care chemotherapy and procedures, building standardized pathways for infection control, transfusion safety, and rehabilitation. They teach and mentor fellows, contribute to institutional audits and outcomes research, and collaborate on national registries. By aligning cutting-edge therapies with pragmatic Indian healthcare realities, they focus on safety, access, and long-term quality of life.
Aplastic anemia
thalassemia
leukemia
PNH
MDS
BMT (auto/allo/haplo)
lymphomas
myeloma
benign hematology
MBBS
MD (Medicine)
DM (Clinical Hematology)
Built high-volume BMT programs across NCR
focuses on access, outcomes, and donor registry collaborations
Research/registries in BMT outcomes and benign hematology
awareness initiatives
Built high-volume BMT programs across NCR
Focuses on access, outcomes, and donor registry collaborations
Research/registries in BMT outcomes and benign hematology
awareness initiatives
CMC Vellore has been consistently ranked among the top medical institutions in India for clinical excellence and academic contribution.
It has received national and international recognition for pioneering work in hematology, oncology, and transplant services.
The institution’s quality assurance standards and NABH accreditation highlight its leadership in medical education, patient safety, and compassionate healthcare delivery.
Apollo Hospitals, Mumbai, has received national and international awards for pioneering cancer care, patient safety, and clinical excellence. It is NABH and JCI accredited.
© 2025 CAR T-Shell Therapy. All rights reserved.
Harnessing the power of your immune system to fight cancer—personalized, innovative, and life-changing treatment.
